RT Journal Article
SR Electronic
T1 1091 Tigilanol Tiglate is a small molecule oncolytic that induces immunogenic cell death and promotes immune cell infiltration into human tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1200
OP A1200
DO 10.1136/jitc-2023-SITC2023.1091
VO 11
IS Suppl 1
A1 Cullen, Jason K
A1 Yap, Pei-Yi
A1 Ferguson, Blake
A1 Bruce, Zara C
A1 Koyama, Motoko
A1 Handoko, Herlina
A1 Johns, Jenny
A1 Stewart, Praphaporn
A1 Ogbourne, Steven M
A1 Reddell, Paul W
A1 Boyle, Glen M
A1 Parsons, Peter G
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1200.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.